Diffuse Hypermetabolism at Bone Marrow in F-18 FDG PET/CT: Correlation with Bone Marrow Biopsy and Complete Blood Cell Counts / 핵의학분자영상
Nuclear Medicine and Molecular Imaging
;
: 35-39, 2009.
Artículo
en Coreano
| WPRIM
| ID: wpr-59152
ABSTRACT
PURPOSE:
Increased FDG uptake in the bone marrow has been reported in patients taking erythropoietin or granulocyte-colony stimulating factor (G-CSF). The aim of this study is to investigate the correlation between F-18 FDG uptake in the bone marrow and bone marrow finding, hematological parameters. MATERIALS ANDMETHODS:
Twenty patients who had diffuse FDG uptake at the bone marrow and received hematological examinations, bone marrow biopsy within 10 days before or after PET/CT were enrolled in this study. Among them, 11 patients were excluded; 4 patients received G-CSF or erythropoietin before PET/CT. Seven patients showed definite pathology in a bone marrow biopsy. The parameters included the measurement of WBC, hemoglobin, platelet and cellularity of the bone marrow.RESULTS:
Bone marrow FDG uptake was correlated with a low hemoglobin but not WBC, platelet. Histopathologic findings in marrow biopsies were various normal finding (n=3), hyperplasia of granulocytic cells (n=2), eosinophilic hyperplasia (n=1), reactive lymphoid nodules (n=1), hypercelluar marrow (n=1), hypocelluar marrow (n=1). All patients except two, showed normal marrow celluarity.CONCLUSION:
FDG uptake by bone marrow correlated with anemia but not WBC, platelet, bone marrow cellularity.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Biopsia
/
Recuento de Células Sanguíneas
/
Células Sanguíneas
/
Plaquetas
/
Médula Ósea
/
Examen de la Médula Ósea
/
Hemoglobinas
/
Factor Estimulante de Colonias de Granulocitos
/
Eritropoyetina
/
Eosinófilos
Límite:
Humanos
Idioma:
Coreano
Revista:
Nuclear Medicine and Molecular Imaging
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS